Symbol="VKTX"
AssetType="Common Stock"
Name="Viking Therapeutics Inc"
Description="Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders. The company is headquartered in San Diego, California."
CIK="1607678"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="12340 EL CAMINO REAL, SUITE 250, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1289426000"
EBITDA="None"
PERatio="None"
PEGRatio="-0.03"
BookValue="3.86"
DividendPerShare="0"
DividendYield="0"
EPS="-0.94"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.173"
ReturnOnEquityTTM="-0.269"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.94"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="33.8"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.865"
EVToRevenue="-"
EVToEBITDA="-2.068"
Beta="0.536"
num_52WeekHigh="25.72"
num_52WeekLow="2.535"
num_50DayMovingAverage="18.17"
num_200DayMovingAverage="12.73"
SharesOutstanding="99839000"
DividendDate="None"
ExDividendDate="None"
symbol="VKTX"
open="13.04"
high="13.21"
low="12.62"
price="12.71"
volume="2049150.00"
latest_trading_day="2023-08-07"
previous_close="13.10"
change="-0.39"
change_percent="-2.9771%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="29"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="71"
Volume_recent_avg="4147657"
Change_recent_avg="-0.06"
Delta_recent_avg="1.22"
Variance_recent_avg="0.61"
Change_ratio_recent_avg="-0.49"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="71"
Aroon_momentum_negative="29"
image_negative_thumbnail_id_1="517"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0088.jpeg"
image_negative_thumbnail_id_2="96"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0080.jpeg"
image_neutral_thumbnail_id_1="577"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0022.jpeg"
image_neutral_thumbnail_id_2="531"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0068.jpeg"
image_positive_thumbnail_id_1="668"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0040.jpeg"
image_positive_thumbnail_id_2="705"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0003.jpeg"
image_professor_thumbnail_id_1="1168"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
image_professor_thumbnail_id_2="1187"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
